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Abstract
Objective: To determine the impact of pharmacist conducted Comprehensive Medication Review (CMR) follow-up within seven days
after discharge on (1) readmission rates, (2) detection of drug related problems, (3) and changes in Hospital Consumer Assessment of
Healthcare Providers and Systems (HCAHPS) scores. Design: Rates of re-admission for pneumonia, congestive heart failure (CHF), or
myocardial infarction (MI), within 30 days of discharge are compared between patients receiving a CMR from the pharmacist to a
historical control group not receiving the service. The CMR documentation is reviewed to classify any detected drug related
problems. Overall HCAHPS scores for the hospital are compared for the three months prior to instituting this service and the three
months during the service. Setting: Patients were discharged from a 101-bed acute care hospital located in rural West Virginia. The
community pharmacist worked with the hospital to contact patients after discharge to demonstrate a partnership between inpatient
and outpatient care. Patients: Patients were included if they had a discharge diagnosis of pneumonia, congestive heart failure (CHF),
or myocardial infarction (MI), and were returning to self-care or family-care. If discharged between 10/12/2012 and 12/11/2012
they were included in the historical control group. If discharged between 12/12/2012 and 2/12/2012 they were offered the CMR
service and included in the intervention group. Intervention: Patients received a telephone call two to seven days following discharge
from a pharmacist who conducted the Comprehensive Medication Review (CMR). Results: Patients who participated in a CMR via the
telephone had decreased 30-day readmission rates compared to the historical control group (16% v 33%). Overall 22 significant drug
therapy problems were identified among patients. HCAHPS scores for the questions “Did you receive communication regarding your
medications” increased during the study time period (65% vs 72%). Conclusion: The mixed results of available data from previous
studies on pharmacist inclusion in the discharge process focuses heavily on counseling before the patient is discharged. Results of
this study show community pharmacist partnership in discharge follow-up can also assist in decreasing readmissions, detecting drug
related problems, and increasing patient satisfaction.

Introduction
According to the Centers for Medicare and Medicaid Services
(CMS), approximately 20% of Medicare patients are
readmitted within 30 days. (1) Patients admitted to a hospital
due to pneumonia, myocardial infarction, or congestive heart
failure have been identified by CMS as high risk populations
for readmission. In an effort to improve overall health
management for these high-risk groups, CMS has announced
decreases in reimbursement rates for hospitals in the event
that a patient is re-admitted for the same diagnosis within 30
days of discharge. CMS now also promotes prompt follow-up
visits after a patient is discharged, by increasing the
reimbursement rate for an outpatient evaluation and
Corresponding author: Brittany Snodgrass, PharmD
Assistant Professor, Department of Pharmacy Practice
University of Charleston School of Pharmacy
2300 MacCorkle Ave SE, Charleston, WV 25304
Office: 304-357-4963, Fax: 304-357-4868
http://z.umn.edu/INNOVATIONS

2013, Vol. 4, No. 4, Article 138

management visit if its (a) coupled with verbal patient
contact within 48 hours of discharge, and (b) the provider
visit is held within 7 to 14 days of discharge.
It has been found that 20% of patients experience an adverse
event (ADE) following discharge, with 66% of those being
medication related (2). Among these, six medication classes
were implicated as causative agents of the ADEs in 87% of
cases. These included anti-infectives, corticosteroids,
cardiovascular medications, analgesics, anticoagulants and
antiepileptics. The most common reasons for ADEs included
the lack of appropriate drug monitoring and the lack of
evaluation of predictable medication side effects. (3)
Recently, there has been great attention on methods to
reduce readmissions, decrease adverse drug events, and
increase patient understanding of their medications upon
discharge. Programs like Project RED (Re-engineered
Discharge) (4) the Care Transitions Program (5) and Project
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BOOST (Better outcomes for older adults through safe
transitions) (6) have all demonstrated methods that are
successful in reducing readmissions.
These three projects target reducing readmissions by focusing
on steps in a patient’s transition from one setting of care to
another, known as “transitions of care” (TOC). One of the
frequently studied areas includes patients discharged from
hospital to home. Pharmacist involvement in the transitions
from hospital to home has been shown to be beneficial at
various points during the discharge process. (7) According to
the PILL-CVD study, pharmacist medication reconciliation and
discharge counseling was shown not to be beneficial in
reducing clinically important medication errors in the 30 days
following discharge. It is important to note while this study
focused on patients with heart failure and acute coronary
syndromes, they were of a low health literacy level. (8) In
contrast, Schnipper, et al. found that providing pharmacist
discharge counseling and follow-up 3 to 5 days post-discharge
was associated with a decreased rate of preventable ADEs
following discharge. (9)
Previous literature regarding pharmacist involvement has
focused on discharge counseling on medications provided by
the pharmacist at the bedside. (7) A recent systematic review
of medication reconciliation identified pharmacists as key
players in discharge processes. (10) Overall, the most
frequently studied post-discharge interventions are follow-up
calls with patients. All of these included medication
reconciliation.
Three studies have measured post-discharge follow-up calls
with medication reconciliation and a review of follow-up
instructions provided by different members of the healthcare
team. (7) Two studies found no effect on the rate of 30-day
readmission, while one showed an effect with follow-up calls
completed by pharmacists on detection of preventable
adverse drug events (ADEs) and decreased visits to the
Emergency Department. (11) This mixed result from the
performance of medication reconciliation introduces a
question of the utility of an accurate medication list versus
the same list compounded by pharmacist counseling.
A closer look at the definitions of medication reconciliation
and CMR help identify the difference that may be introduced
by having a pharmacist perform medication reconciliation
and discharge follow-up. According to CMS, medication
reconciliation is defined as the process of identifying the most
accurate list of all medications that the patient is taking,
including name, dosage, frequency, and route, by comparing
the medical record to an external list of medications obtained
from a patient, hospital, or other provider. (12) The National
Medication Therapy Management Advisory Board defines a
http://z.umn.edu/INNOVATIONS
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CMR as: a systematic process of collecting patient-specific
information, assessing medication therapies to identify
medication-related problems, developing a prioritized list of
medication-related problems, and creating a plan to resolve
them with the patient, caregiver and/or prescriber. (13)
Inherent in this definition is that a CMR includes medication
reconciliation, but is augmented by the professional expertise
of a pharmacist.
A CMR is an interactive person-to-person consultation
conducted between the patient and/or caregiver and the
pharmacist designed to improve patients’ knowledge of their
prescription, over-the-counter (OTC) medications, herbal
therapies and dietary supplements, identify and address
problems or concerns that patients may have, and empower
patients to self-manage their medications and their health
condition(s). (13) CMRs are frequently conducted by
community pharmacists, but most of the literature focuses on
interventions that align with the definition of medication
reconciliation rather than a CMR. (12)
Currently, there are few studies highlighting the use of a
community pharmacist in this realm. For example, Walgreens
is promoting their WellTransitions® program which
incorporates bedside delivery of medications, follow-up with
the patient at 9 and 25 days post-discharge by a pharmacist,
and connections with their primary care providers. (14) Based
on the minimal amount of evidence of community pharmacist
involvement in the discharge follow-up process, the objective
of this study was to determine the impact of a pharmacist
conducted CMR via telephone within 7 days post-discharge
on readmission rates, detection of drug related problems,
and patient satisfaction scores through HCAHPS.
Methods
This pilot was approved by the University of Charleston
Institutional Review Board and representatives of the study
hospital and conducted from December 12, 2012 through
March 12, 2013 at the study hospital. Patients were
identified by a nurse case manager and invited to participate
in the study if they had a diagnosis of congestive heart failure
(CHF), pneumonia, or myocardial infarction (MI) and gave
informed consent. Those included must also be 18 years or
older, have access to a telephone, and speak
English. Patients were identified and contacted during the
first three months of the study (December 12, 2012 through
February 12, 2013), while the remaining month was left for
30-day follow-up on readmission status with those patients
called within the final month (March 2013).
The pharmacist with training and experience in performing a
CMR reviewed discharge medication records and instructions
prior to calling patients. Participating patients were
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contacted between two and seven days post-discharge. The
pharmacist attempted to call patients three times before
excluding them from the study.
The pharmacist used a standardized CMR questionnaire form
to document the encounter. (Appendix A) The CMR included
indication for therapy, dosing/duration, side effects,
adherence or access to medications, drug/drug interactions,
and drug/food interactions for each medication, selfmonitoring for the admitting/discharge diagnosis, selfmonitoring for medication side effects, immunization record
evaluation, and specific questions related to disease states of
CHF and COPD. Questions related to COPD were included
because the diagnosis of pneumonia leads to a high-incidence
of re-admission among COPD patients. All patients were
asked about any difficulty filling prescriptions following
discharge. Drug therapy problems and discrepancies were
documented using the Coleman Medication Discrepancy
©
Tool (MDT) for community dwelling adults. (5) After the call,
a second clinical pharmacist was consulted to confirm
evaluation and documentation of drug related
problems. Patients were then mailed a reconciled list of their
medications with self-monitoring guidance. At least 30 days
following discharge, the patient’s EHR was reviewed for any
readmissions. Patients were called at this point to review
readmission status to other facilities such as the ER, urgent
care, or unscheduled physician visits.
The historical control group consisted of patients discharged
with one of the target diagnoses in the three months prior to
the study period during the dates October 12, 2012 through
December 11, 2012. These patients received the standard
discharge medication counseling from nursing staff and did
not receive a telephone follow-up call at the 30 day mark to
determine readmission status. The pharmacist reviewed
patient records to detect any readmissions within 30 days of
discharge
Results
During the three month study period, 25 patients met the
inclusion criteria (Figure 1). Of these, 7 were lost due to
inability to contact within the designated time frame (Figure
1). A total of 18 patients received the CMR service. In the
intervention group there were three (16%) patients
readmitted within 30 days of discharge, however only two of
these readmissions were related to the initial diagnosis (11%),
while one (5%) was not. (Table 2) These re-admissions were
to the study hospital and were detected by the record review
process.
The historical control group consisted of 24 community
dwelling patients discharged with one of the diagnoses listed
(Table 1). Of these, eight (33%) were readmitted to the study
http://z.umn.edu/INNOVATIONS
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hospital with the same diagnosis (Table 2). Since these
patients received no 30-day follow-up call for readmission
status, there is potential for higher readmission rates for the
control group to other facilities, which would be unaccounted
for in our study.
Hospital Consumer Assessment of Health Care Providers and
Services (HCAHPS) scores were compared for the control and
intervention groups. HCAHPS is a survey sent to all patients
following their hospital stay. One of the main focuses of
HCAHPS is on the importance of communication about
medications. When those in the control group were asked if
they received communication about their medications, 65%
answered yes. During the three month study period, 72% of
patients answered yes to this question, showing an
improvement in patient satisfaction for this domain. These
results for HCAHPS scores included all patients surveyed by
the hospital, and not just those included in the study.
There were 22 significant drug therapy problems detected in
the intervention group. Several patients experienced more
than 1 drug therapy problem (Table 3). The most common
problems identified were needs additional therapy (9),
adverse drug reactions (3), and patient non-adherence
(3). Often when patients were called, it was found they had
not picked up their new discharge medications from the
pharmacy or were non-adherent with other medications at
home. This may have potentially led to their admission or a
future re-admission. Not all drug therapy problems were
related to a patient’s admitting diagnosis; however, any
problem may have led to additional physician visits or
hospital admissions in the future. This demonstrates the
importance of reviewing all medications with a patient
following discharge, and not only their new or altered
regimen.
Discussion
Pharmacist involvement in transitions of care elements has
been continually shown to be beneficial at various points in
the healthcare spectrum a patient may access. A recent
systematic review of medication reconciliation identified
pharmacists as key players in discharge process. (10) Previous
literature focused on pharmacist involvement at predischarge counseling (7). The most frequently studied postdischarge interventions are follow-up calls, but these were
rarely studied in isolation.
As a community pharmacist serving as a liaison between the
inpatient and outpatient setting, there were barriers to
initially be recognized as a contributor to preventing
readmissions within the acute care setting. When presenting
the concept of this project to hospital administration and
staff, a lot of initial groundwork had to be done. Most
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hospital employees were unfamiliar with the concept of a
CMR and that CMRs are provided at their local
pharmacy. Inpatient medications change too rapidly to
conduct a CMR versus traditional medication reconciliation in
the institutional setting. CMRs target self-care patients with a
variety of disease states, which puts community pharmacists
in an ideal position to provide these important services.
In this study, the institution granted the pharmacist access to
the electronic health record (EHR). However, the lack of
access to this critical information is often a significant barrier
to communication in the community pharmacy setting. The
lack of access for hospitals, physicians, and pharmacies to
patient health information could be easily remedied by the
implementation of a universal EHR. There is very little
literature discussing the role of community pharmacists
participating in these interventions. This pilot study
demonstrates that a community pharmacist can serve as a
connection for patients in the outpatient setting in
conjunction with their physician(s) and hospital. It offers
patients another piece to a support system in medication
management at home. Future research may include having
follow-up visits with patients in a community pharmacy
setting to review medication issues prior to a follow-up visit
with their physician to determine the impact of face to face
contact versus telephone contact.
Through the phone call, the pharmacist was able to answer
questions the patient had regarding their medications, refer
patients to their physician when appropriate, and even assist
patients with getting their new medications through
pharmacy delivery services. Not all drug therapy problems
were related to a patient’s admitting diagnosis, but any
problem may have led to additional physician visits or
hospital admissions in the future. This demonstrates the
importance of reviewing all medications with a patient
following discharge, and not only their new or altered
regimen.
The decreased number of readmissions in the intervention
group may have been related to the detection of drug related
problems, reinforcement of self-monitoring principles,
counseling received on previous home medications, or the
positive impact of the contact.
Limitations
The small sample size of this pilot study does not provide
enough power to report statistically significant
conclusions. In the future, including patients with additional
diagnoses targeted by CMS for readmission reduction, or
extending the time frame for data collection may result in a
larger sample size. The sample size was also limited by the
difficulty contacting patients via phone within the time frame
http://z.umn.edu/INNOVATIONS
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required. This might have been improved if patients had
been given a specific appointment time for the phone CMR
session, or if multiple pharmacists were offering the service
at various times. Completing a CMR is a time consuming
process and requires additional staffing resources to continue
as a mainstay of pharmacist involvement in discharge
interventions. One addition to improve the efficiency of the
pharmacist would be using pharmacy technicians to arrange
the phone appointments, and secure commitment from the
patient for the appointment time.
A variety of communication challenges existed during the
study. Patients could not always be contacted at home
during the study time frame of two to seven days postdischarge. When using one pharmacist with multiple other
responsibilities to make all follow-up calls, this presents a
challenge. No analysis was conducted to determine the best
time frame for contacting patients.
Readmissions were categorized based on admitting
diagnosis. While this is appropriate to measure the ultimate
financial impact on the hospital secondary to financial
penalties imposed by CMS for readmissions, this method did
not discern whether readmissions were medication related,
due to another disease, or medication injury.
Finally, although a standard CMR form was used for all
patients, due to variability in their medications and disease
states, the call could have proceeded in various directions. If
multiple pharmacists were conducting this service in the
future, a more standardized script for each disease state
would need to be implemented.
Conclusion
The burden for patients following discharge and reducing
readmissions is a key area of practice and current research,
especially concerning the financial penalties associated with
readmissions. This pilot study demonstrates that pharmacist
involvement in discharge follow-up can be important to
reducing readmissions and detecting drug related problems
at the study hospital. This reinforces the value of using a
medication specialist to improve the quality of transitions of
care. To conduct successful research in the future and to
increase the volume of patients contacted, institutions should
use more than one pharmacist to provide such services. This
would allow for a greater number of patients to be reached in
a specific time frame. Enlisting the help of technician staff, or
finding a more efficient way of scheduling appointments
would lessen the burden of the process, allowing the
pharmacist to more correctly focus their time on the patient.
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Figure 1: Patient Inclusion and Exclusion
Total Patients Discharged from Hospital with an index
diagnosis of PNA, MI, or CHF
N=42
Eligible patients lost to exclusion criteria/no informed
consent
N=17
Patients unable to reach in 7 days
N=7

Patients contacted with CMR
N=18

Table 1: Characteristics and Diagnoses of Population
Characteristic
N
Age range
Diagnosis of CHF
Diagnosis of PNA
Diagnosis of MI
>1 Inclusion Diagnosis

Intervention Group
18
49-82
11
8
1
4

Control Group
24
45-92
17
5
2
3

CHF=Congestive Heart Failure, PNA=Pneumonia, MI=Myocardial Infarction

http://z.umn.edu/INNOVATIONS

2013, Vol. 4, No. 4, Article 138

INNOVATIONS in pharmacy

6

Original Research

PRACTICE-BASED RESEARCH
Table 2: 30-day Readmission Rates

N
Index diagnosis at discharge (some patients had more than 1 diagnosis)
PNA
MI
CHF
30-day readmissions
Index diagnosis readmission
Readmission unrelated to initial diagnosis

Intervention Group

Historic Control Group

18

24

8
1
11
3 (16%)
2
1

12
2
10
8 (33%)
5
3

CHF=Congestive Heart Failure, PNA=Pneumonia, MI=Myocardial Infarction

Table 3: Shows the frequency of drug related problems in the intervention group.
Number of Drug Therapy Problems Detected
0
1-3
3-6
>6

Number of Patients
2
14
2
0

Table 4: Examples of medication discrepancies detected
Problem
Communication/Documentation Failure (An example of
an issue detected outside the normal scope of drug
therapy problems due to system failure
Adverse Drug Reaction

Dose too high
Needs Additional Drug Therapy

http://z.umn.edu/INNOVATIONS

Evaluation
The patient’s discharge medication records indicated rosuvastatin, but
the follow-up call found the patient was taking lovastatin. This system
level issue of conflicting information between sources is easily clarified
for the primary care provider on the CMR documents.
A patient was discharged with an antibiotic and steroids for
pneumonia. During the follow-up call she described symptoms similar
to thrush. The pharmacist referred the patient to her physician for
evaluation and treatment. This is a patient level event.
A patient was taking 80 mg of citalopram daily. The maximum
recommended dose is 40 mg daily.
Patients with a diagnosis of CHF were missing key drug therapies such as
ACE-Inhibition or Beta Blockade.
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Appendix A:
Impact of Complete Medication Review (CMR) telephone discharge follow-up
to Reduce Readmissions and Drug Related Problems

Name/Study Number
Discharge Date:
Date of Follow-Up Call
Prepared to discuss all
medications?

Yes

No

Yes

No

What pharmacy do you use
to fill your medications?
(verify compliance)
Did you have trouble getting
your prescriptions filled
after discharge?

Astham/COPD
Cardiovascular
GERD/PUD
Seizures

Post MI

Current
Medications

Patient Disease States: (circle all that apply)—PNA
Depression
Heart Failure
Mental Health
Diabetes
Hyperlipidemia
Fluid Retention
Hypertension
Migraine Headaches
Thyroid Disorders
Chronic Pain
Stroke
Other-neuropathy

OA/RA
Osteoporosis

Readmission Category: (circle all that apply)
Pneumonia
Heart Failure

>5 medications

Disease State Specific Questions:
Indication
Dosing
Duration

Comments

Asthma/COPD:
Question

Yes

No

Contrain
dicated

Not
Relev
ant

Are you using a short-acting β2-agonist (SABA)/"rescue inhaler" more than 2 days
a week (not including pre-exercise dose)?
Based onreview and standards of care, is the patient’s medication therapy for
asthma appropriate?
Do you understand the purpose of each medication used to treat asthma (rescue
vs. controller, scheduled vs. as needed dosing)
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Heart Failure:
Question

Yes

No

Contrain
dicated

Not
Relev
ant

Is the patient currently taking a beta blocker?
Is the patient currently taking a diuretic?
Based on review and standards of care, is current medication therapy for Heart
Failure appropriate?
Are you weighing yourself daily?
Does patient know to call his/her physician when weight gain of 2 lbs. or greater
occurs overnight or 5 lbs. or greater occurs in one week?
Are you experiencing symptoms of possible worsening of heart failure (weight
gain, fluid retention, dry cough, increased shortness of breath, elevating the head
with pillow(s) to sleep or sleeping sitting up)?
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